HEK cell expression

Transient expression in HEK293 cells is the fastest reliable route from a sequence to purified protein. Plasmid DNA is delivered to a suspension culture, the cells express the protein for several days without ever integrating the gene, and you harvest the supernatant for a secreted protein or the pellet for an intracellular one. For antibody panels, receptor ectodomains and most secreted proteins, this is the default.

Why HEK, and when

HEK293 derivatives grown in suspension are human cells, so they do human post-translational modifications, including the N-linked glycosylation that many antigens need to fold and behave. They transfect efficiently, they grow in chemically defined media, and the timeline from DNA to protein is about a week.

CHO cells are the other common choice. They generally express at higher titer and they are what most therapeutic programs use for production, but human glycosylation patterns differ, and transient CHO expression is less forgiving at small scale. A practical division is HEK for discovery panels and difficult antigens, CHO when the material needs to resemble what a production cell line would make.

What makes a run work

• Construct design. Signal peptide, tag placement, linker choice and codon usage all change yield. For antibodies, the heavy and light chain ratio is worth optimizing rather than assuming.
• Cell health. Viability and doubling time before transfection predict the run better than any other single variable. Cells recovering from a bad passage express poorly.
• Transfection chemistry. Polyethylenimine is the workhorse for cost and scale. Lipid reagents often perform better on small, difficult constructs.
• Feeding and harvest timing. Titer usually climbs for several days while viability falls. Harvesting on viability rather than on a fixed day protects you from degradation and from proteases released by dying cells.
• Temperature shift. Dropping the temperature after transfection slows growth and can improve folding and titer for a difficult protein. It costs time, so it is a lever, not a default.

Where it stops being the right tool

Transient expression is not a substitute for a stable line when you need the same material, lot after lot, over a long program. It also has limits with proteins that are toxic to the host, proteins that need chaperones or partners the host does not have, and multi-pass membrane proteins, which usually need a different system altogether.

What comes out, and what to check

Assume nothing about the protein until it is characterized. For an antibody panel, the useful checks after purification are concentration, purity by a size-based method, integrity on a gel under reducing and non-reducing conditions, and identity by mass where it matters. A panel that skips these checks tends to produce assay results nobody can interpret later, because the differences between candidates turn out to be differences in what was actually in the tube.

How we run it

We express in HEK cells in-house, purify, and report concentration, purity and integrity for every lot, so the assay stage starts from material with known quality instead of an assumption.